A detailed history of Atria Investments LLC transactions in Dexcom Inc stock. As of the latest transaction made, Atria Investments LLC holds 15,320 shares of DXCM stock, worth $1.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,320
Previous 26,320 41.79%
Holding current value
$1.23 Million
Previous $2.98 Million 65.62%
% of portfolio
0.01%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$64.0 - $116.06 $704,000 - $1.28 Million
-11,000 Reduced 41.79%
15,320 $1.03 Million
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $252,499 - $321,490
2,289 Added 9.53%
26,320 $2.98 Million
Q1 2024

May 21, 2024

SELL
$114.22 - $140.1 $44,088 - $54,078
-386 Reduced 1.58%
24,031 $3.33 Million
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $28,459 - $46,808
-377 Reduced 1.52%
24,417 $3.03 Million
Q3 2023

Nov 07, 2023

SELL
$86.06 - $137.93 $376,770 - $603,857
-4,378 Reduced 15.01%
24,794 $2.31 Million
Q2 2023

Aug 04, 2023

BUY
$112.47 - $130.98 $181,076 - $210,877
1,610 Added 5.84%
29,172 $3.75 Million
Q1 2023

May 10, 2023

SELL
$104.0 - $122.92 $415,168 - $490,696
-3,992 Reduced 12.65%
27,562 $3.2 Million
Q4 2022

Jan 31, 2023

SELL
$84.98 - $122.67 $65,859 - $95,069
-775 Reduced 2.4%
31,554 $3.57 Million
Q3 2022

Nov 01, 2022

SELL
$76.35 - $94.18 $58,484 - $72,141
-766 Reduced 2.31%
32,329 $2.6 Million
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $1.58 Million - $3.09 Million
23,215 Added 234.97%
33,095 $2.47 Million
Q1 2022

May 02, 2022

BUY
$94.08 - $130.2 $95,114 - $131,632
1,011 Added 11.4%
9,880 $5.06 Million
Q4 2021

Feb 04, 2022

BUY
$129.87 - $162.82 $97,012 - $121,626
747 Added 9.2%
8,869 $4.76 Million
Q3 2021

Nov 16, 2021

BUY
$106.71 - $143.18 $141,924 - $190,429
1,330 Added 19.58%
8,122 $4.44 Million
Q2 2021

Aug 10, 2021

BUY
$80.99 - $107.93 $249,368 - $332,316
3,079 Added 82.92%
6,792 $2.9 Million
Q1 2021

May 11, 2021

BUY
$84.79 - $104.74 $53,163 - $65,671
627 Added 20.32%
3,713 $1.33 Million
Q4 2020

Feb 12, 2021

SELL
$78.0 - $104.5 $12,168 - $16,302
-156 Reduced 4.81%
3,086 $1.14 Million
Q3 2020

Nov 05, 2020

SELL
$95.51 - $112.95 $1.05 Million - $1.25 Million
-11,042 Reduced 77.3%
3,242 $1.34 Million
Q2 2020

Sep 22, 2020

BUY
$62.68 - $105.34 $895,321 - $1.5 Million
14,284 New
14,284 $5.79 Million
Q1 2020

May 15, 2020

SELL
$47.79 - $75.63 $160,287 - $253,663
-3,354 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$36.62 - $57.29 $6,921 - $10,827
189 Added 5.97%
3,354 $734,000
Q3 2019

Nov 14, 2019

SELL
$35.53 - $43.8 $5,684 - $7,008
-160 Reduced 4.81%
3,165 $472,000
Q2 2019

Aug 26, 2019

BUY
$27.84 - $38.92 $92,568 - $129,409
3,325 New
3,325 $511,000
Q2 2019

Aug 09, 2019

SELL
$27.84 - $38.92 $88,753 - $124,076
-3,188 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$28.07 - $38.18 $4,238 - $5,765
-151 Reduced 4.52%
3,188 $380,000
Q4 2018

Feb 12, 2019

BUY
$26.99 - $37.37 $14,169 - $19,619
525 Added 18.66%
3,339 $400,000
Q3 2018

Oct 09, 2018

SELL
$23.35 - $36.72 $6,864 - $10,795
-294 Reduced 9.46%
2,814 $403,000
Q2 2018

Jul 13, 2018

SELL
$17.54 - $25.22 $4,349 - $6,254
-248 Reduced 7.39%
3,108 $295,000
Q1 2018

Apr 30, 2018

BUY
$13.06 - $18.54 $43,829 - $62,220
3,356 New
3,356 $249,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.